Skip to main content

Table 1 Basic information

From: The effect of loteprednol suspension eye drops after corneal transplantation

  1 % prednisolone acetate eye drop group (n = 96) 0.5 % loteprednol suspension eye drop group (n = 138) P value
Age (years) 51.03 ± 14.15 49.38 ± 15.77 0.413
 Male, n (%) 55 (57.29) 94 (68.12) 0.090
Surgical method, n (%)    0.246
 PKP 54 (56.25) 67 (48.55)  
 LKP 42 (43.75) 71 (51.45)  
Preoperative diagnosis, n (%)    0.468
 Bullous keratopathy 3 (3.13) 2 (1.45)  
 Keratoconus 14 (14.58) 22 (15.94)  
 Corneal degeneration 7 (7.29) 5 (3.62)  
 Corneal mass 2 (2.08) 1 (0.72)  
 Corneal leukoplakia 21 (21.88) 28 (20.29)  
 Corneal dystrophy 8 (8.33) 4 (2.90)  
 Keratitis 4 (4.17) 11 (7.97)  
 Pseudopterygium 1 (1.04) 1 (0.72)  
 Non-infectious corneal ulcer 3 (3.13) 4 (2.90)  
 Infective corneal ulcer 27 (28.13) 53 (38.41)  
 Infectious corneal ulcer perforation 6 (6.25) 7 (5.07)  
Preoperative IOP 12.41 ± 2.90 12.28 ± 3.07 0.754
Preoperative BCVA 2.04 ± 1.06 2.17 ± 1.09 0.339
  1. BCVA best corrected visual acuity, IOP intraocular pressure
  2. Age, preoperative IOP and preoperative BCVA were tested using a student’s t-test. The gender, surgical method and preoperative diagnosis were analyzed by χ2 test